Suchergebnisse - "Xu, Tian-Li"

PubPharm (8)

1

The ApoB/A-1 ratio is independently associated with subclinical arteriosclerosis and arterial stiffness in type 2 diabetes patients

enthalten in: ResearchSquare.com | 2023

von Tang, M. | Xu, T. | Shen, L. | +3

2

Association of serum fibroblast growth factor 19 levels with arteriosclerosis parameters assessed by arterial stiffness and atherogenic index of plasma in patients with type 2 diabetes

enthalten in: Diabetology & metabolic syndrome | 2020

von Liu, W. | Tang, M. | Xu, T. | +7

3

Association of serum fibroblast growth factor 19 levels with arteriosclerosis parameters assessed by arterial stiffness and atherogenic index of plasma in patients with type 2 diabetes

enthalten in: Diabetology & metabolic syndrome | 2020

von Liu, W. | Tang, M. | Xu, T. | +7

4

Association of serum fibroblast growth factor 19 levels with arteriosclerosis parameters assessed by arterial stiffness and atherogenic index of plasma in patients with type 2 diabetes

enthalten in: Diabetology & metabolic syndrome | 2020

von Liu, W. | Tang, M. | Xu, T. | +7

5

Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients

enthalten in: Diabetology & metabolic syndrome | 2019

von Tang, M. | Su, J. | Xu, T. | +3

6

Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients

enthalten in: Diabetology & metabolic syndrome | 2019

von Tang, M. | Su, J. | Xu, T. | +3

7

Minimally Invasive Versus Traditional Open Transforaminal Lumbar Interbody Fusion for the Treatment of Single-Level Spondylolisthesis Grades 1 and 2 : A Systematic Review and Meta-Analysis

enthalten in: World neurosurgery | 2019

von Qin, R. | Liu, B. | Zhou, P. | +6

8

Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients

enthalten in: Diabetology & metabolic syndrome | 2019

von Tang, M. | Su, J. | Xu, T. | +3

1
[1]